These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 17414259)

  • 81. The reply.
    Vieweg WV; Hasnain M; Howland RH
    Am J Med; 2013 Jun; 126(6):e23. PubMed ID: 23684406
    [No Abstract]   [Full Text] [Related]  

  • 82. An open-label trial of citalopram for major depression in patients with hepatitis C.
    Gleason OC; Yates WR; Isbell MD; Philipsen MA
    J Clin Psychiatry; 2002 Mar; 63(3):194-8. PubMed ID: 11926717
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial.
    Leombruni P; Amianto F; Delsedime N; Gramaglia C; Abbate-Daga G; Fassino S
    Adv Ther; 2006; 23(3):481-94. PubMed ID: 16912031
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Citalopram approved for treatment of depression.
    Am J Health Syst Pharm; 1998 Oct; 55(19):1963. PubMed ID: 9784778
    [No Abstract]   [Full Text] [Related]  

  • 85. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Acute maniform reaction to a single dose of escitalopram in a social phobic patient--an atypical jitteriness syndrome?
    Muhtz C; Agorastos A; Kellner M
    Pharmacopsychiatry; 2009 Nov; 42(6):291-2. PubMed ID: 19924592
    [No Abstract]   [Full Text] [Related]  

  • 87. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Serotonin syndrome in the elderly after antidepressive monotherapy.
    Fischer P
    J Clin Psychopharmacol; 1995 Dec; 15(6):440-2. PubMed ID: 8748434
    [No Abstract]   [Full Text] [Related]  

  • 89. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
    Mrazek DA; Biernacka JM; McAlpine DE; Benitez J; Karpyak VM; Williams MD; Hall-Flavin DK; Netzel PJ; Passov V; Rohland BM; Shinozaki G; Hoberg AA; Snyder KA; Drews MS; Skime MK; Sagen JA; Schaid DJ; Weinshilboum R; Katzelnick DJ
    J Clin Psychopharmacol; 2014 Jun; 34(3):313-7. PubMed ID: 24743713
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sexual dysfunction during treatment of major depressive disorder with vilazodone, citalopram, or placebo: results from a phase IV clinical trial.
    Clayton AH; Gommoll C; Chen D; Nunez R; Mathews M
    Int Clin Psychopharmacol; 2015 Jul; 30(4):216-23. PubMed ID: 26039688
    [TBL] [Abstract][Full Text] [Related]  

  • 91. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol.
    Williams LM; Rush AJ; Koslow SH; Wisniewski SR; Cooper NJ; Nemeroff CB; Schatzberg AF; Gordon E
    Trials; 2011 Jan; 12():4. PubMed ID: 21208417
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Selective serotonin re-uptake inhibitors (SSRIs) and alopecia areata.
    Ruiz-Doblado S; Carrizosa A; García-Hernández MJ; Rodríguez-Pichardo A
    Int J Dermatol; 1999 Oct; 38(10):798-9. PubMed ID: 10561061
    [No Abstract]   [Full Text] [Related]  

  • 93. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.
    Mundo E; Bianchi L; Bellodi L
    J Clin Psychopharmacol; 1997 Aug; 17(4):267-71. PubMed ID: 9241005
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A case report of hyponatremia with citalopram use.
    Iraqi A; Baickle E
    J Am Med Dir Assoc; 2004; 5(1):64-5. PubMed ID: 14726801
    [No Abstract]   [Full Text] [Related]  

  • 95. [ Action mechanisms of modern antidepressives].
    Müller WE
    Pharm Unserer Zeit; 2004; 33(4):288-95. PubMed ID: 15287689
    [No Abstract]   [Full Text] [Related]  

  • 96. Pharmacology Update: The Selective Serotonin Reuptake Inhibitors.
    Lorman WJ
    J Addict Nurs; 2018; 29(4):260-261. PubMed ID: 30507822
    [No Abstract]   [Full Text] [Related]  

  • 97. [Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time].
    Odar-Cederlöf I; Hjelmström P; Jersenius I; Andersson M; Rasmanis G; Bergman U
    Lakartidningen; 2006 Apr 5-11; 103(14):1112-4. PubMed ID: 16681095
    [No Abstract]   [Full Text] [Related]  

  • 98. [Is there a preferable SSRI preparation when it comes to sexual adverse effects?].
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1949. PubMed ID: 18681379
    [No Abstract]   [Full Text] [Related]  

  • 99. Eyelash Loss Secondary to Escitalopram But Not to Sertraline: A Case Report.
    Norton DJ; Cates C
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27722027
    [No Abstract]   [Full Text] [Related]  

  • 100. Electric sensations: neglected symptom of escitalopram discontinuation.
    Feth N; Cattapan-Ludewig K; Jaquenoud Sirot E
    Am J Psychiatry; 2006 Jan; 163(1):160. PubMed ID: 16390910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.